NasdaqCM - Nasdaq Real Time Price USD

Catalyst Pharmaceuticals, Inc. (CPRX)

Compare
21.48 +0.36 (+1.70%)
At close: 4:00 PM EST
21.40 -0.08 (-0.37%)
After hours: 5:44 PM EST

Valuation Measures

Annual
Monthly
Currency in USD
Download
Current9/30/20246/30/20243/31/202412/31/20239/30/2023
Market Cap 2.52B 2.36B 1.83B 1.88B 1.79B 1.25B
Enterprise Value 2.08B 1.99B 1.52B 1.75B 1.67B 1.07B
Trailing P/E 17.90 35.50 27.66 25.30 30.56 11.46
Forward P/E 10.62 9.77 11.10 10.83 10.66 6.35
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales 5.59 5.44 4.37 4.55 5.50 4.39
Price/Book 3.81 3.88 3.27 4.85 5.17 3.32
Enterprise Value/Revenue 4.52 4.57 3.70 4.39 4.81 3.54
Enterprise Value/EBITDA 9.84 16.23 13.35 14.60 16.70 6.93
9/30/2023 - 11/8/2006

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 9/30/2024

Profitability

Profit Margin 31.01%
Operating Margin (ttm) 39.56%

Management Effectiveness

Return on Assets (ttm) 18.35%
Return on Equity (ttm) 28.29%

Income Statement

Revenue (ttm) 460.48M
Revenue Per Share (ttm) 4.00
Quarterly Revenue Growth (yoy) 25.30%
Gross Profit (ttm) --
EBITDA 211.43M
Net Income Avi to Common (ttm) 142.8M
Diluted EPS (ttm) 1.18
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 442.33M
Total Cash Per Share (mrq) 3.71
Total Debt (mrq) 3.28M
Total Debt/Equity (mrq) 0.50%
Current Ratio (mrq) 5.11
Book Value Per Share (mrq) 5.54

Cash Flow Statement

Operating Cash Flow (ttm) 224.58M
Levered Free Cash Flow (ttm) 150.67M

Trading Information

Stock Price History

Beta (5Y Monthly) 0.75
52 Week Range 3 50.21%
S&P 500 52-Week Change 3 30.47%
52 Week High 3 24.27
52 Week Low 3 13.00
50-Day Moving Average 3 21.10
200-Day Moving Average 3 17.57

Share Statistics

Avg Vol (3 month) 3 945.22k
Avg Vol (10 day) 3 1.25M
Shares Outstanding 5 119.27M
Implied Shares Outstanding 6 119.27M
Float 8 103.02M
% Held by Insiders 1 5.98%
% Held by Institutions 1 81.72%
Shares Short (10/31/2024) 4 6.01M
Short Ratio (10/31/2024) 4 8.2
Short % of Float (10/31/2024) 4 6.25%
Short % of Shares Outstanding (10/31/2024) 4 5.04%
Shares Short (prior month 9/30/2024) 4 5.75M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq?=?Most Recent Quarter
  • ttm?=?Trailing Twelve Months
  • yoy?=?Year Over Year
  • lfy?=?Last Fiscal Year
  • fye?=?Fiscal Year Ending

Related Tickers